[HTML][HTML] High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
…, S Fafi-Kremer, V Castelain, F Schneider… - Intensive care …, 2020 - Springer
Purpose Little evidence of increased thrombotic risk is available in COVID-19 patients. Our
purpose was to assess thrombotic risk in severe forms of SARS-CoV-2 infection. Methods All …
purpose was to assess thrombotic risk in severe forms of SARS-CoV-2 infection. Methods All …
Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels
…, J Helms, C Pauzet, O Collange, F Schneider… - Radiology, 2020 - pubs.rsna.org
… Schneider disclosed no relevant relationships. AL disclosed no relevant relationships.
PB disclosed no relevant relationships. … García-Ceberino, NayaFaro-Míguez, Francisco …
PB disclosed no relevant relationships. … García-Ceberino, NayaFaro-Míguez, Francisco …
Brain MRI findings in severe COVID-19: a retrospective observational study
…, V Mutschler, Y Hansmann, PM Mertes, F Schneider… - Radiology, 2020 - pubs.rsna.org
Background Brain MRI parenchymal signal abnormalities have been associated with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Purpose To describe the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Purpose To describe the …
[HTML][HTML] Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients
…, V Castelain, M Ohana, M Anheim, F Schneider… - Critical care, 2020 - Springer
Background Neurotropism of SARS-CoV-2 and its neurological manifestations have now
been confirmed. We aimed at describing delirium and neurological symptoms of COVID-19 in …
been confirmed. We aimed at describing delirium and neurological symptoms of COVID-19 in …
[HTML][HTML] Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
…, R Felten, F Luca, B Goichot, F Schneider… - The Lancet …, 2021 - thelancet.com
Background Elevated proinflammatory cytokines are associated with greater COVID-19 severity.
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2)
…, S Chevalier, C Quentin, Q Maestraggi, F Schneider… - The Lancet, 2018 - thelancet.com
Background Whether the route of early feeding affects outcomes of patients with severe
critical illnesses is controversial. We hypothesised that outcomes were better with early first-line …
critical illnesses is controversial. We hypothesised that outcomes were better with early first-line …
Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study
…, D Stephan, M Pinget, F Schneider - Diabetes …, 2003 - Am Diabetes Assoc
OBJECTIVE—To study the effect of systemic hyperbaric oxygenation (HBO) therapy on the
healing course of nonischemic chronic diabetic foot ulcers. RESEARCH DESIGN AND …
healing course of nonischemic chronic diabetic foot ulcers. RESEARCH DESIGN AND …
Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study
…, S Caillard, O Collange, PM Mertes, F Schneider… - Neurology, 2020 - AAN Enterprises
Objective To describe neuroimaging findings and to report the epidemiologic and clinical
characteristics of patients with coronavirus disease 2019 (COVID-19) with neurologic …
characteristics of patients with coronavirus disease 2019 (COVID-19) with neurologic …
Hubs of brain functional networks are radically reorganized in comatose patients
…, F Renard, M Schenck, F Schneider… - Proceedings of the …, 2012 - National Acad Sciences
Human brain networks have topological properties in common with many other complex
systems, prompting the following question: what aspects of brain network organization are …
systems, prompting the following question: what aspects of brain network organization are …
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
…, A Thomas, A Viari, D Sanlaville, F Schneider… - Science translational …, 2022 - science.org
The drivers of critical coronavirus disease 2019 (COVID-19) remain unknown. Given major
confounding factors such as age and comorbidities, true mediators of this condition have …
confounding factors such as age and comorbidities, true mediators of this condition have …
